
Olaparib Plus Pembrolizumab Shows Efficacy in HRR Gene–Mutated Advanced Tumors With/Without HRD Positivity
Olaparib Plus Pembrolizumab in HRR Gene–Mutated Tumors | Image Credit: © Kellie Ehrmann/ MJH Life Sciences Using AI Olaparib (Lynparza) in combination with pembrolizumab (Keytruda) showed promising activity in patients with homologous recombination …